Cancer

Cover image for Vol. 122 Issue 4

Edited By: Fadlo R. Khuri, MD

Impact Factor: 5.068

ISI Journal Citation Reports © Ranking: 2014: 32/211 (Oncology)

Online ISSN: 1097-0142

Associated Title(s): Cancer Cytopathology, CA: A Cancer Journal for Clinicians

Highlighted Papers

  • Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: The role of systematic and targeted biopsies

    Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: The role of systematic and targeted biopsies

    Pathway for the performance of magnetic resonance (MR)-ultrasound-guided fusion biopsy in a sample patient.

  • Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy

    Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy

    Differences in defining criteria between the current 7th edition and the proposed 8th edition.

  • Resveratrol inhibits ovarian tumor growth in an in vivo mouse model

    Resveratrol inhibits ovarian tumor growth in an in vivo mouse model

    Tumor burden assessed by 2-deoxy-2-[18F]fludeoxyglucose ([18F]FDG) in vivo after treatment with resveratrol.

  • Using computer-extracted image phenotypes from tumors on breast magnetic resonance imaging to predict breast cancer pathologic stage

    Using computer-extracted image phenotypes from tumors on breast magnetic resonance imaging to predict breast cancer pathologic stage

    A representative breast magnetic resonance study depicts a sagittal, fat-saturated, T1-weighted image with an annotation identifying the tumor and measurement (“radiologist-size”).

  • Comprehensive genomic profiling of 295 cases of clinically advanced urothelial carcinoma of the urinary bladder reveals a high frequency of clinically relevant genomic alterations

    Comprehensive genomic profiling of 295 cases of clinically advanced urothelial carcinoma of the urinary bladder reveals a high frequency of clinically relevant genomic alterations

    A woman aged 60 years with metastatic urothelial carcinoma of the urinary bladder (UCB) developed disease progression while receiving chemotherapy with cisplatin and gemcitabine.

  • Cervical cancer control in Latin America: A call to action

    Cervical cancer control in Latin America: A call to action

    Continuum of prevention and screening events that can reduce mortality from cervical cancer.

  • Delivering a research-enabled multistakeholder partnership for enhanced patient care at a population level: The Northern Ireland Comprehensive Cancer Program

    Delivering a research-enabled multistakeholder partnership for enhanced patient care at a population level: The Northern Ireland Comprehensive Cancer Program

    The PICan (Pathology Integromics in Cancer Platform) translational platform.

  • Oncolytic reovirus in combination with chemotherapy in metastatic or recurrent non–small cell lung cancer patients with KRAS-activated tumors

    Oncolytic reovirus in combination with chemotherapy in metastatic or recurrent non–small cell lung cancer patients with KRAS-activated tumors

    Stepwise and schematic representation of the reovirus type 3 Dearing mechanism of action in the cytoplasm of cancer cells with an activated ras signaling pathway.

  • Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: The role of systematic and targeted biopsies
  • Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy
  • Resveratrol inhibits ovarian tumor growth in an in vivo mouse model
  • Using computer-extracted image phenotypes from tumors on breast magnetic resonance imaging to predict breast cancer pathologic stage
  • Comprehensive genomic profiling of 295 cases of clinically advanced urothelial carcinoma of the urinary bladder reveals a high frequency of clinically relevant genomic alterations
  • Cervical cancer control in Latin America: A call to action
  • Delivering a research-enabled multistakeholder partnership for enhanced patient care at a population level: The Northern Ireland Comprehensive Cancer Program
  • Oncolytic reovirus in combination with chemotherapy in metastatic or recurrent non–small cell lung cancer patients with KRAS-activated tumors

SEARCH

SEARCH BY CITATION